* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
11 | Ubiquitination | PLVPSSQKALLLELK CCCCHHHHHHHHHHC | 42.84 | 21906983 | |
18 | Ubiquitination | KALLLELKGLQEEPV HHHHHHHCCCCCCCC | 48.47 | 21906983 | |
63 | Ubiquitination | GYFKARLKFPIDYPY CEEEEEEECCCCCCC | 43.47 | 21906983 | |
68 | Phosphorylation | RLKFPIDYPYSPPAF EEECCCCCCCCCHHH | 12.56 | 20068231 | |
70 | Phosphorylation | KFPIDYPYSPPAFRF ECCCCCCCCCHHHHH | 27.81 | 20068231 | |
71 | Phosphorylation | FPIDYPYSPPAFRFL CCCCCCCCCHHHHHH | 21.65 | 20068231 | |
80 | Ubiquitination | PAFRFLTKMWHPNIY HHHHHHHHHCCCCCC | 41.98 | - | |
89 | Phosphorylation | WHPNIYETGDVCISI CCCCCCCCCCEEEEE | 23.01 | - | |
111 | Phosphorylation | PQSGELPSERWNPTQ CCCCCCCCCCCCCCH | 53.04 | 24719451 | |
150 | Ubiquitination | DASVMYRKWKESKGK CHHHHHHHHHHHCCC | 45.17 | PubMed | |
157 | Ubiquitination | KWKESKGKDREYTDI HHHHHCCCCHHHHHH | 58.30 | - | |
162 | Phosphorylation | KGKDREYTDIIRKQV CCCCHHHHHHHHHHH | 18.90 | - | |
166 | Methylation | REYTDIIRKQVLGTK HHHHHHHHHHHHCCC | 24.56 | - | |
167 | Ubiquitination | EYTDIIRKQVLGTKV HHHHHHHHHHHCCCC | 34.06 | - | |
182 | Ubiquitination | DAERDGVKVPTTLAE CCCCCCCCCCCHHHH | 48.29 | - | |
185 | Phosphorylation | RDGVKVPTTLAEYCV CCCCCCCCHHHHHHH | 37.11 | 29978859 | |
186 | O-linked_Glycosylation | DGVKVPTTLAEYCVK CCCCCCCHHHHHHHH | 20.21 | 28657654 | |
186 | Phosphorylation | DGVKVPTTLAEYCVK CCCCCCCHHHHHHHH | 20.21 | 29978859 | |
190 | Phosphorylation | VPTTLAEYCVKTKAP CCCHHHHHHHHCCCC | 9.27 | 29978859 | |
193 | Ubiquitination | TLAEYCVKTKAPAPD HHHHHHHHCCCCCCC | 40.52 | - | |
203 | Phosphorylation | APAPDEGSDLFYDDY CCCCCCCCCCCCCCC | 29.15 | 17461777 | |
207 | Phosphorylation | DEGSDLFYDDYYEDG CCCCCCCCCCCCCCC | 18.40 | 26074081 | |
222 | Phosphorylation | EVEEEADSCFGDDED CCCCCHHHHCCCCCC | 20.56 | 17461777 | |
231 | Phosphorylation | FGDDEDDSGTEES-- CCCCCCCCCCCCC-- | 60.99 | 12037680 | |
233 | Phosphorylation | DDEDDSGTEES---- CCCCCCCCCCC---- | 40.30 | 16123592 | |
236 | Phosphorylation | DDSGTEES------- CCCCCCCC------- | 39.01 | 12037680 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
162 | T | Phosphorylation | Kinase | RPS6KA1 | Q15418 | GPS |
203 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
203 | S | Phosphorylation | Kinase | CK2_GROUP | - | PhosphoELM |
203 | S | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
203 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
222 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
222 | S | Phosphorylation | Kinase | CK2_GROUP | - | PhosphoELM |
222 | S | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
222 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
231 | S | Phosphorylation | Kinase | CK2_GROUP | - | PhosphoELM |
231 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
231 | S | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
231 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
233 | T | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
233 | T | Phosphorylation | Kinase | CK2 | - | Uniprot |
233 | T | Phosphorylation | Kinase | CK2_GROUP | - | PhosphoELM |
233 | T | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
236 | S | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
236 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
236 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
236 | S | Phosphorylation | Kinase | CK2_GROUP | - | PhosphoELM |
- | K | Ubiquitination | E3 ubiquitin ligase | SAG | P10523 | PMID:10851089 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UB2R1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UB2R1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Cdc34 C-terminal tail phosphorylation regulates Skp1/cullin/F-box(SCF)-mediated ubiquitination and cell cycle progression."; Sadowski M., Mawson A., Baker R., Sarcevic B.; Biochem. J. 405:569-581(2007). Cited for: PHOSPHORYLATION AT SER-203; SER-222 AND SER-231, AND FUNCTION. | |
"CK2-dependent phosphorylation of the E2 ubiquitin conjugating enzymeUBC3B induces its interaction with beta-TrCP and enhances beta-catenindegradation."; Semplici F., Meggio F., Pinna L.A., Oliviero S.; Oncogene 21:3978-3987(2002). Cited for: ENZYME ACTIVITY, FUNCTION, INTERACTION WITH BTRC, PHOSPHORYLATION ATSER-231, AND MUTAGENESIS OF CYS-93; LEU-97 AND SER-231. | |
"Phosphorylation of the human ubiquitin-conjugating enzyme, CDC34, bycasein kinase 2."; Block K., Boyer T.G., Yew P.R.; J. Biol. Chem. 276:41049-41058(2001). Cited for: INTERACTION WITH CSNK2B, PHOSPHORYLATION AT SER-203; SER-222; SER-231;THR-233 AND SER-236, MUTAGENESIS OF SER-203; SER-222; SER-231; THR-233AND SER-236, AND SUBCELLULAR LOCATION. |